Conventional chondrosarcoma in a survivor of rhabdoid tumor: Enlarging the spectrum of tumors associated with SMARCB1 germline mutations

American Journal of Surgical Pathology

Volumn 36, Issue 12, 2012, Pages 1892-1896

  Forest, Fabien ^a   David, Audrey ^b   Arrufat, Sandrine ^c   Pierron, Gaelle ^c   Ranchere Vince, Dominique ^d   Stephan, Jean Louis ^b,e   Clemenson, Alix ^a,e   Delattre, Olivier ^c,f   Bourdeaut, Franck ^f,g  

^a Département de Pathologie   (France)

^b CENTRE HOSPITALIER   (France)

^c Functionnal Genomics Section   (France)

^d CENTRE LÉON BÉRARD   (France)

^e UNIVERSITÉ JEAN MONNET   (France)

^f INSTITUT CURIE   (France)

^g INSTITUT CURIE   (France)

Author keywords

chondrosarcoma; pediatric; predisposition; rhabdoid tumor; SMARCB1

Indexed keywords

DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADOLESCENT; ARTICLE; CHEMISTRY; CHILD; CHONDROSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; EXON; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE TUMOR; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOLOGY; RHABDOID TUMOR; SECOND CANCER; THORAX TUMOR;

ADOLESCENT; CHILD; CHONDROSARCOMA; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EXONS; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MANDIBULAR NEOPLASMS; NEOPLASMS, SECOND PRIMARY; RHABDOID TUMOR; THORACIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84869993131     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31826cbe7a     Document Type: Article

References (28)

1. Roberts CW, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer. 2004;4:133-142.
2. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74-79.
3. Sevenet N, Sheridan E, Amram D, et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet. 1999;65:1342-1348.
4. Sevenet N, Lellouch-Tubiana A, Schofield D, et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet. 1999;8:2359-2368.
5. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394:203-206.
6. Roberts CW, Leroux MM, Fleming MD, et al. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell. 2002;2:415-425.
7. Bourdeaut F, Lequin D, Brugieres L, et al. Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor. Clin Cancer Res. 2011;17:31-38.
8. Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7-15.
9. Kordes U, Gesk S, Fruhwald MC, et al. Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosomes Cancer. 2010;49:176-181.
10. Boyd C, Smith MJ, Kluwe L, et al. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet. 2008;74:358-366.
11. Hulsebos TJ, Plomp AS, Wolterman RA, et al. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007;80:805-810.
12. Sestini R, Bacci C, Provenzano A, et al. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat. 2008;29:227-231.
13. Christiaans I, Kenter SB, Brink HC, et al. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple menin-giomas. J Med Genet. 2011;48:93-97.
14. Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005;65:4012-4019.
15. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647-652.
16. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009;33:542-550.
17. Mobley BC, McKenney JK, Bangs CD, et al. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas. Acta Neuro-pathol. 2010;120:745-753.
18. Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol. 2011;35: e47-e63.
19. Gleason BC, Fletcher CD. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol. 2007;31:1813-1824.
20. Kohashi K, Oda Y, Yamamoto H, et al. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondro-sarcoma. Am J Surg Pathol. 2008;32:1168-1174.
21. Bourdeaut F, Freneaux P, Thuille B, et al. hSNF5/INI1-deficient tumors and rhabdoid tumors are convergent but not fully overlapping entities. J Pathol. 2007;211:323-330.
22. Swensen JJ, Keyser J, Coffin CM, et al. Familial occurrence of schwannomas and malignant rhabdoid tumor associated with a duplication in SMARCB1. J Med Genet. 2009;46:68-72.
23. Smith MJ, Wallace AJ, Bowers NL, et al. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics. 2012;13:141-145.
24. Jackson EM, Shaikh TH, Gururangan S, et al. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet. 2007;122:117-127.
25. Ammerlaan AC, Houben MP, Tijssen CC, et al. Secondary meningi-oma in a long-term survivor of atypical teratoid/rhabdoid tumor with a germline INI1 mutation. Childs Nerv Syst. 2008;24:855-857.
26. Jennes I, Pedrini E, Zuntini M, et al. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum Mutat. 2009;30:1620-1627.
27. Amary MF, Damato S, Halai D, et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet. 2011;43:1262-1265.
28. Pansuriya TC, van Eijk R, d'Adamo P, et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011;43:1256-1261.